Super-enhancer hypermutation alters oncogene expression in B cell lymphoma

Diffuse large B cell lymphoma (DLBCL) is the most common B cell non-Hodgkin lymphoma and remains incurable in around 40% of patients. Efforts to sequence the coding genome identified several genes and pathways that are altered in this disease, including potential therapeutic targets 1 – 5 . However,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature (London) 2022-07, Vol.607 (7920), p.808-815
Hauptverfasser: Bal, Elodie, Kumar, Rahul, Hadigol, Mohammad, Holmes, Antony B., Hilton, Laura K., Loh, Jui Wan, Dreval, Kostiantyn, Wong, Jasper C. H., Vlasevska, Sofija, Corinaldesi, Clarissa, Soni, Rajesh Kumar, Basso, Katia, Morin, Ryan D., Khiabanian, Hossein, Pasqualucci, Laura, Dalla-Favera, Riccardo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!